Yair Lotan, MD
Dr. Lotan is a Professor of the Department of Urology at UT Southwestern and
Jane and John Justin Distinguished Chair in Urology,
In Honor of Claus G. Roehrborn, M.D. He is chief of urologic oncology. He graduated from Baylor College of Medicine and did his residency training at UT Southwestern Medical Center. His practice focuses on oncology and endourology. His research is focused on the areas of bladder cancer screening, biomarkers, decision analysis and health economics. Dr. Lotan has participated in multiple collaborative studies involving early detection of bladder cancer. Dr. Lotan is also PI on several investigator-initiated studies evaluating the role of urine and tissue markers in management of bladder cancer. He has published over 500 peer reviewed articles and has been invited to write multiple book chapters, reviews and editorials. He leads the disease oriented team for genitor-urinary malignancies at the UT Southwestern Simmons Cancer Center. He has participated in writing the AUA/ASCO/ASTRO muscle invasive bladder cancer guidelines. He is on editorial staff of other urologic journals. He was the chair of AUA Core Curriculum committee. He is also on the scientific advisory board of the Bladder Cancer Advocacy Network.
Financial relationships
-
Attribution:SelfType of financial relationship:OtherIneligible company:SynergoDate added:Date updated:07/15/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:EngeneDate added:Date updated:07/15/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:nucleixDate added:Date updated:07/15/2024
-
Attribution:SelfType of financial relationship:OtherIneligible company:nucleixDate added:Date updated:07/15/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Merck IncDate added:Date updated:07/15/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:astra zenecaDate added:Date updated:07/15/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:vessi MedicalDate added:Date updated:07/15/2024
-
Attribution:SelfType of financial relationship:OtherIneligible company:UrogenDate added:Date updated:07/15/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:MDxHealthDate added:Date updated:07/15/2024
-
Attribution:SelfType of financial relationship:OtherIneligible company:MDxHealthDate added:Date updated:07/15/2024